Publications:

---

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: TET2: 4144C>T; H1382Y

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

---

Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection.

Cancers

Bernardi, Simona S; Farina, Mirko M; Bosio, Katia K; Di Lucanardo, Anna A; Leoni, Alessandro A; Re, Federica F; Polverelli, Nicola N; Turra, Alessandro A; Morello, Enrico E; Accorsi Buttini, Eugenia E; Zollner, Tatiana T; Bonvicini, Cristian C; Malagola, Michele M; Russo, Domenico D

Publication Date: 2022-09-16

Variant appearance in text: TET2: H1382Y

PubMed Link: 36139664

Variant Present in the following documents:

• cancers-14-04504.pdf

View BVdb publication page

---

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: TET2: 4144C>T; H1382Y

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.

Nature Genetics

Kar, Siddhartha P SP; Quiros, Pedro M PM; Gu, Muxin M; Jiang, Tao T; Mitchell, Jonathan J; Langdon, Ryan R; Iyer, Vivek V; Barcena, Clea C; Vijayabaskar, M S MS; Fabre, Margarete A MA; Carter, Paul P; Petrovski, Slavé S; Burgess, Stephen S; Vassiliou, George S GS

Publication Date: 2022-08

Variant appearance in text: TET2: H1382Y

PubMed Link: 35835912

Variant Present in the following documents:

• 41588_2022_1121_MOESM3_ESM.xlsx, sheet 4

View BVdb publication page

---

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Nature Communications

Gounder, Mrinal M MM; Agaram, Narasimhan P NP; Trabucco, Sally E SE; Robinson, Victoria V; Ferraro, Richard A RA; Millis, Sherri Z SZ; Krishnan, Anita A; Lee, Jessica J; Attia, Steven S; Abida, Wassim W; Drilon, Alexander A; Chi, Ping P; Angelo, Sandra P D' SP; Dickson, Mark A MA; Keohan, Mary Lou ML; Kelly, Ciara M CM; Agulnik, Mark M; Chawla, Sant P SP; Choy, Edwin E; Chugh, Rashmi R; Meyer, Christian F CF; Myer, Parvathi A PA; Moore, Jessica L JL; Okimoto, Ross A RA; Pollock, Raphael E RE; Ravi, Vinod V; Singh, Arun S AS; Somaiah, Neeta N; Wagner, Andrew J AJ; Healey, John H JH; Frampton, Garrett M GM; Venstrom, Jeffrey M JM; Ross, Jeffrey S JS; Ladanyi, Marc M; Singer, Samuel S; Brennan, Murray F MF; Schwartz, Gary K GK; Lazar, Alexander J AJ; Thomas, David M DM; Maki, Robert G RG; Tap, William D WD; Ali, Siraj M SM; Jin, Dexter X DX

Publication Date: 2022-06-15

Variant appearance in text: TET2: H1382Y

PubMed Link: 35705558

Variant Present in the following documents:

• 41467_2022_30496_MOESM2_ESM.xls, sheet 1

View BVdb publication page

---

Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated NPM1 and TET2.

Internal Medicine (Tokyo, Japan)

Saito, Kenki K; Sato, Takayuki T; Notohara, Kenji K; Nannya, Yasuhito Y; Ogawa, Seishi S; Ueda, Yasunori Y

Publication Date: 2022-11-01

Variant appearance in text: TET2: H1382Y

PubMed Link: 35185048

Variant Present in the following documents:

• 1349-7235-61-3265.pdf

View BVdb publication page

---

Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia

Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP

Publication Date: 2022-02

Variant appearance in text: TET2: H1382Y

PubMed Link: 34413458

Variant Present in the following documents:

• 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.

Experimental Hematology & Oncology

Ye, Yingying Y; Ding, Ning N; Mi, Lan L; Shi, Yunfei Y; Liu, Weiping W; Song, Yuqin Y; Shu, Shaokun S; Zhu, Jun J

Publication Date: 2021-02-05

Variant appearance in text: TET2: 4144C>T; H1382Y

PubMed Link: 33546774

Variant Present in the following documents:

• 40164_2021_200_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

TET2 missense variants in human neoplasia. A proposal of structural and functional classification.

Molecular Genetics & Genomic Medicine

Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P

Publication Date: 2019-07

Variant appearance in text: TET2: 4144C>T; His1382Tyr

PubMed Link: 31187595

Variant Present in the following documents:

View BVdb publication page

---

TETs Regulate Proepicardial Cell Migration through Extracellular Matrix Organization during Zebrafish Cardiogenesis.

Cell Reports

Lan, Yahui Y; Pan, Heng H; Li, Cheng C; Banks, Kelly M KM; Sam, Jessica J; Ding, Bo B; Elemento, Olivier O; Goll, Mary G MG; Evans, Todd T

Publication Date: 2019-01-15

Variant appearance in text: TET2: H1382Y

PubMed Link: 30650362

Variant Present in the following documents:

• Main text
• nihms-1518822.pdf

View BVdb publication page

---

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.

Nature

Fraietta, Joseph A JA; Nobles, Christopher L CL; Sammons, Morgan A MA; Lundh, Stefan S; Carty, Shannon A SA; Reich, Tyler J TJ; Cogdill, Alexandria P AP; Morrissette, Jennifer J D JJD; DeNizio, Jamie E JE; Reddy, Shantan S; Hwang, Young Y; Gohil, Mercy M; Kulikovskaya, Irina I; Nazimuddin, Farzana F; Gupta, Minnal M; Chen, Fang F; Everett, John K JK; Alexander, Katherine A KA; Lin-Shiao, Enrique E; Gee, Marvin H MH; Liu, Xiaojun X; Young, Regina M RM; Ambrose, David D; Wang, Yan Y; Xu, Jun J; Jordan, Martha S MS; Marcucci, Katherine T KT; Levine, Bruce L BL; Garcia, K Christopher KC; Zhao, Yangbing Y; Kalos, Michael M; Porter, David L DL; Kohli, Rahul M RM; Lacey, Simon F SF; Berger, Shelley L SL; Bushman, Frederic D FD; June, Carl H CH; Melenhorst, J Joseph JJ

Publication Date: 2018-06

Variant appearance in text: TET2: H1382Y

PubMed Link: 29849141

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.

Haematologica

Ji, Meng-Meng MM; Huang, Yao-Hui YH; Huang, Jin-Yan JY; Wang, Zhao-Fu ZF; Fu, Di D; Liu, Han H; Liu, Feng F; Leboeuf, Christophe C; Wang, Li L; Ye, Jing J; Lu, Yi-Ming YM; Janin, Anne A; Cheng, Shu S; Zhao, Wei-Li WL

Publication Date: 2018-04

Variant appearance in text: TET2: H1382Y

PubMed Link: 29305415

Variant Present in the following documents:

• 2017.182444.Ji_SUPPL.pdf

View BVdb publication page

---

Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway.

Oncogene

Wu, M-J MJ; Kim, M R MR; Chen, Y-S YS; Yang, J-Y JY; Chang, C-J CJ

Publication Date: 2017-06-01

Variant appearance in text: TET2: H1382Y

PubMed Link: 28218902

Variant Present in the following documents:

• Main text
• onc2016467a.pdf

View BVdb publication page

---

AF9 promotes hESC neural differentiation through recruiting TET2 to neurodevelopmental gene loci for methylcytosine hydroxylation.

Cell Discovery

Qiao, Yunbo Y; Wang, Xiongjun X; Wang, Ran R; Li, Yuanyuan Y; Yu, Fang F; Yang, Xianfa X; Song, Lu L; Xu, Guoliang G; Chin, Y Eugene YE; Jing, Naihe N

Publication Date: 2015

Variant appearance in text: TET2: H1382Y

PubMed Link: 27462416

Variant Present in the following documents:

• Main text
• celldisc201517.pdf

View BVdb publication page

---

Overlapping Requirements for Tet2 and Tet3 in Normal Development and Hematopoietic Stem Cell Emergence.

Cell Reports

Li, Cheng C; Lan, Yahui Y; Schwartz-Orbach, Lianna L; Korol, Evgenia E; Tahiliani, Mamta M; Evans, Todd T; Goll, Mary G MG

Publication Date: 2015-08-18

Variant appearance in text: TET2: H1382Y

PubMed Link: 26257178

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Feature-based classification of amino acid substitutions outside conserved functional protein domains.

Thescientificworldjournal

Gemovic, Branislava B; Perovic, Vladimir V; Glisic, Sanja S; Veljkovic, Nevena N

Publication Date: 2013

Variant appearance in text: TET2: H1382Y

PubMed Link: 24348198

Variant Present in the following documents:

• 948617.f1.pdf

View BVdb publication page

---

TET2 promotes histone O-GlcNAcylation during gene transcription.

Nature

Chen, Qiang Q; Chen, Yibin Y; Bian, Chunjing C; Fujiki, Ryoji R; Yu, Xiaochun X

Publication Date: 2013-01-24

Variant appearance in text: TET2: H1382Y

PubMed Link: 23222540

Variant Present in the following documents:

• Main text
• NIHMS418911-supplement-1.pdf
• nihms-418911.pdf

View BVdb publication page

---

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Nature

Ko, Myunggon M; Huang, Yun Y; Jankowska, Anna M AM; Pape, Utz J UJ; Tahiliani, Mamta M; Bandukwala, Hozefa S HS; An, Jungeun J; Lamperti, Edward D ED; Koh, Kian Peng KP; Ganetzky, Rebecca R; Liu, X Shirley XS; Aravind, L L; Agarwal, Suneet S; Maciejewski, Jaroslaw P JP; Rao, Anjana A

Publication Date: 2010-12-09

Variant appearance in text: TET2: H1382Y

PubMed Link: 21057493

Variant Present in the following documents:

• NIHMS247005-supplement-3.pdf

View BVdb publication page

---